|
業務類別
|
Biotechnology |
|
業務概覽
|
Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin. |
| 公司地址
| 44 West Gay Street, Suite 400, West Chester, PA, USA, 19380 |
| 電話號碼
| +1 484 453-3300 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.verrica.com |
| 員工數量
| 76 |
| Mr. John J. Kirby |
Interim Chief Financial Officer and Interim Principal Accounting Officer |
美元 480.00K |
20/04/2026 |
| Mr. David Zawitz |
Chief Operating Officer |
-- |
20/04/2026 |
| Dr. Noah L. Rosenberg, M.D. |
Chief Medical Officer |
美元 173.86K |
20/04/2026 |
| Dr. Jayson Rieger |
Director, Chief Executive Officer and President |
美元 300.00K |
20/04/2026 |
|
|
| Mr. Mark A. Prygocki, Sr |
Independent Director |
20/04/2026 |
| Mr. Paul B. Manning |
Chairman of the Board |
20/04/2026 |
| Dr. Gavin Corcoran |
Director |
20/04/2026 |
| Mr. Sean Stalfort |
Director |
20/04/2026 |
| Mr. Charles Frantzreb |
Director |
20/04/2026 |
| Dr. Diem Nguyen, M.B.A.,PhD |
Independent Director |
20/04/2026 |
| Dr. Lawrence Eichenfield, M.D. |
Independent Director |
20/04/2026 |
| Dr. Jayson Rieger |
Director, Chief Executive Officer and President |
20/04/2026 |
|
|
|
|
